{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:06:10Z","timestamp":1776474370062,"version":"3.51.2"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.2967\/jnumed.117.205120","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T13:45:39Z","timestamp":1514468739000},"page":"427-433","source":"Crossref","is-referenced-by-count":13,"title":["Hospice Admission and Survival After <sup>18<\/sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry"],"prefix":"10.2967","volume":"59","author":[{"given":"Ilana F.","family":"Gareen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Hillner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Makineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenghai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony F.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathan M.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry A.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2021051712114862000_59.3.427.1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.06.1175"},{"key":"2021051712114862000_59.3.427.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.043687"},{"key":"2021051712114862000_59.3.427.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.5631"},{"key":"2021051712114862000_59.3.427.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056713"},{"key":"2021051712114862000_59.3.427.5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24000"},{"key":"2021051712114862000_59.3.427.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.037200"},{"key":"2021051712114862000_59.3.427.7","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000592"},{"key":"2021051712114862000_59.3.427.8","doi-asserted-by":"publisher","DOI":"10.1038\/460312a"},{"key":"2021051712114862000_59.3.427.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.130005"},{"key":"2021051712114862000_59.3.427.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.135475"},{"key":"2021051712114862000_59.3.427.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.150391"},{"key":"2021051712114862000_59.3.427.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3996"},{"key":"2021051712114862000_59.3.427.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2009.01.016"},{"key":"2021051712114862000_59.3.427.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-12"},{"key":"2021051712114862000_59.3.427.15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-017-0902-9","article-title":"Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?","volume":"15","author":"Kemp","year":"2017","journal-title":"BMC Med."},{"key":"2021051712114862000_59.3.427.16","unstructured":"Decision memo for positron emission tomography (NaF-18) to identify bone metastasis of cancer (CAG-00065R2). Centers for Medicare & Medicaid Services website. https:\/\/www.cms.gov\/medicare-coverage-database\/details\/nca-decision-memo.aspx?NCAId=279. Accessed January 9, 2018."},{"key":"2021051712114862000_59.3.427.17","unstructured":"Welcome to the Chronic Conditions Data Warehouse. Chronic Conditions Data Warehouse website. https:\/\/www.ccwdata.org\/web\/guest\/home. Accessed January 9, 2018."},{"key":"2021051712114862000_59.3.427.18","unstructured":"Hospice RIF . Research Data Assistance Center website. https:\/\/www.resdac.org\/cms-data\/files\/hospice-rif. Accessed January 9, 2018."},{"key":"2021051712114862000_59.3.427.19","unstructured":"CMS cell size suppression policy. Research Data Assistance Center website. https:\/\/www.resdac.org\/resconnect\/articles\/26. Published May 8, 2017. Accessed January 9, 2018."},{"key":"2021051712114862000_59.3.427.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.158626"},{"key":"2021051712114862000_59.3.427.21","doi-asserted-by":"crossref","first-page":"36001","DOI":"10.18632\/oncotarget.16418","article-title":"18F-fluoride PET\/CT tumor burden quantification predicts survival in breast cancer","volume":"8","author":"Brito","year":"2017","journal-title":"Oncotarget."},{"key":"2021051712114862000_59.3.427.22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13550-017-0264-5","article-title":"3D skeletal uptake of 18F sodium fluoride in PET\/CT images is associated with overall survival in patients with prostate cancer","volume":"7","author":"Lindgren Belal","year":"2017","journal-title":"EJNMMI Res."},{"key":"2021051712114862000_59.3.427.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.166512"},{"key":"2021051712114862000_59.3.427.24","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1200\/JCO.2017.72.2348","article-title":"Quantitative assessment of early [18F]sodium fluoride positron emission tomography\/computed tomography response to treatment in men with metastatic prostate cancer to bone","volume":"35","author":"Harmon","year":"2017","journal-title":"J Clin Oncol."},{"key":"2021051712114862000_59.3.427.25","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.12659\/MSM.902971","article-title":"Clinical characteristics and prognostic factors in bone metastases from lung cancer","volume":"23","author":"Zhang","year":"2017","journal-title":"Med Sci Monit."},{"key":"2021051712114862000_59.3.427.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016022"},{"key":"2021051712114862000_59.3.427.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.207624"},{"key":"2021051712114862000_59.3.427.28","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.394"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.205120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:22:36Z","timestamp":1621282956000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.205120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,28]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,1]]},"published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.2967\/jnumed.117.205120"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.205120","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,28]]}}}